ANTIBIOTICS: CURE AND RISK FACTOR FOR CLOSTRIDIOIDESDIFFICILE INFECTION

Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/34427

Title:	ANTIBIOTICS: CURE AND RISK FACTOR FOR CLOSTRIDIOIDESDIFFICILE INFECTION
Authors:	Mihajlov, Kiril Trajkovska Dokikj, Elena Labachevska Gjatovska, Liljana Kostovski, Marko Jovchevski, Radomir Kovacheva Trpkovska, Danica Ignjatovikj Mihajlova, Ivana
Keywords:	Clostridioides difficile infection C. difficile antimicrobial susceptibility
Issue Date:	22-Apr-2024
Publisher:	Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
Journal:	Academic Medical Journal
Abstract:	Introduction: The major risk factor for acquiring an infection with Clostridioides difficile (CDI) is a long-term antibiotic treatment. Contrarily, the treatment of severe CDI cases involves application of antibiotics like vancomycin or metronidazole. Our aim was to investigate the percentage of resistance to eight antibiotics (vancomycin, metronidazole, tetracycline, clindamycin, erythromycin, imipenem, ciprofloxacin and moxifloxacin) among Clostridioides difficile isolates, indirectly evaluating the risks of acquiring CDI and the risks of therapeutic failure.
URI:	http://hdl.handle.net/20.500.12188/34427
DOI:	10.53582/AMJ2441041m
Appears in Collections:	Faculty of Medicine: Journal Articles

Check